MARKET WIRE NEWS

AbbVie Smashes Earnings, Bets Big On Depression Drug Bretisilocin

Source: SeekingAlpha

2025-08-29 12:37:34 ET

Since my last article, "Why AbbVie's Stock Is A Strong Buy After Q1 2025 Results," AbbVie's stock price (NYSE: ABBV ) (NEOE: ABBV:CA ) has risen 11.5%....

Read the full article on Seeking Alpha

For further details see:

AbbVie Smashes Earnings, Bets Big On Depression Drug Bretisilocin
BeiGene

NASDAQ: BEIGF

BEIGF Trading

0.0% G/L:

$23.75 Last:

100 Volume:

$23.75 Open:

mwn-alerts Ad 300

BEIGF Latest News

BEIGF Stock Data

$38,603,023,416
747,457,849
N/A
299
N/A
Biotechnology & Life Sciences
Healthcare
CH
Basel

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App